Autor

Ergör G

12 de octubre de 2017
Escenarios para gestionar la carga de la enfermedad por hepatitis C y el impacto económico asociado del tratamiento en Turquía
Summary Background Hepatitis C virus (HCV) infection is a significant health problem. The aim of this study is to evaluate the cost-effectiveness of HCV treatment and estimate its economic burden in Turkey. Methods An Excel-based disease progression model was used to estimate the HCV-infected population for 2015-2030. Direct costs in US dollars (USD) including diagnostic, […]

Leer más
5 de mayo de 2014
Estrategias para manejar la carga de morbilidad por el virus de la hepatitis C (VHC)
Summary The number of hepatitis C virus (HCV) infections is projected to decline while those with advanced liver disease will increase. A modeling approach was used to forecast two treatment scenarios: (i) the impact of increased treatment efficacy while keeping the number of treated patients constant and (ii) increasing efficacy and treatment rate. This analysis […]

Leer más
5 de mayo de 2014
La carga de morbilidad presente y futura de la infección por el virus de la hepatitis C (VHC) con el paradigma de tratamiento actual
Summary The disease burden of hepatitis C virus (HCV) is expected to increase as the infected population ages. A modeling approach was used to estimate the total number of viremic infections, diagnosed, treated and new infections in 2013. In addition, the model was used to estimate the change in the total number of HCV infections, […]

Leer más
5 de mayo de 2014
Epidemiología histórica del virus de la hepatitis C (VHC) en países seleccionados
Summary Chronic infection with hepatitis C virus (HCV) is a leading indicator for liver disease. New treatment options are becoming available, and there is a need to characterize the epidemiology and disease burden of HCV. Data for prevalence, viremia, genotype, diagnosis and treatment were obtained through literature searches and expert consensus for 16 countries. For […]

Leer más